Oragenics Inc. 8-K Summary
Business Context and Reporting Period
Oragenics Inc., a Florida-based registrant, filed this Current Report on December 1, 2004, covering events occurring on November 30, 2004. The filing primarily addresses a private placement of equity securities and the disclosure of forward-looking financial estimates.
Key Financial Metrics
The filing reports the closing of a private placement of equity securities with total proceeds of $687,500. The document references a Financial Summary (Exhibit 99.2) containing estimates for the years 2004 through 2006; however, the specific values for revenue, profit, cash flow, margins, debt, or liquidity are not detailed within the text of this 8-K filing.
Material Changes
The primary material change is the successful capital raise of $687,500 via private equity placement. No comparative financial data or year-over-year changes are provided in this specific report text.
Guidance, Outlook, and Risks
Management has prepared a Financial Summary with estimates for 2004-2006 to support the capital raising effort. The company explicitly states it undertakes no obligation to publicly update or revise these estimates in the future. No specific risks or contingencies are detailed in the body of this report beyond the standard nature of forward-looking estimates.
Investor Verification Checklist
- Verify the terms of the private placement by reviewing the attached Press Release (Exhibit 99.1).
- Review the Financial Summary Table (Exhibit 99.2) for the specific 2004-2006 estimates referenced but not listed in the main text.
- Confirm the use of the $687,500 proceeds as described in the press release.
- Note the company's disclaimer regarding the non-updating of the provided financial estimates.